NCT03621046View on ClinicalTrials.gov

Use of Low-dose Zolpidem in Parkinson's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

August 20, 2018

Primary Completion Date

December 31, 2019

Study Completion Date

January 24, 2020

Conditions
Parkinson Disease
Interventions
DRUG

Zolpidem

Zolpidem is a non-benzodiazepine sedative/hypnotic agent usually prescribed for insomnia.

OTHER

Placebo

Placebo

Trial Locations (1)

B15 2TH

University Hospitals Birmingham NHS Foundation Trust, Birmingham

All Listed Sponsors
collaborator

University Hospital Birmingham NHS Foundation Trust

OTHER

lead

Aston University

OTHER

NCT03621046 - Use of Low-dose Zolpidem in Parkinson's Disease | Biotech Hunter | Biotech Hunter